- Home
- OLMA vs ITIC Comparison
OLMA vs ITIC Comparison
Compare OLMA & ITIC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OLMA
- ITIC
- Stock Information
- Founded
- OLMA 2006
- ITIC 1972
- Country
- OLMA United States
- ITIC United States
- Employees
- OLMA N/A
- ITIC N/A
- Industry
- OLMA Biotechnology: Pharmaceutical Preparations
- ITIC Specialty Insurers
- Sector
- OLMA Health Care
- ITIC Finance
- Exchange
- OLMA Nasdaq
- ITIC Nasdaq
- Market Cap
- OLMA 378.9M
- ITIC 440.1M
- IPO Year
- OLMA 2020
- ITIC N/A
- Fundamental
- Price
- OLMA $7.89
- ITIC $248.97
- Analyst Decision
- OLMA Strong Buy
- ITIC
- Analyst Count
- OLMA 5
- ITIC 0
- Target Price
- OLMA $24.00
- ITIC N/A
- AVG Volume (30 Days)
- OLMA 1.0M
- ITIC 28.3K
- Earning Date
- OLMA 11-11-2025
- ITIC 11-04-2025
- Dividend Yield
- OLMA N/A
- ITIC 6.33%
- EPS Growth
- OLMA N/A
- ITIC 25.49
- EPS
- OLMA N/A
- ITIC 17.49
- Revenue
- OLMA N/A
- ITIC $269,460,000.00
- Revenue This Year
- OLMA N/A
- ITIC N/A
- Revenue Next Year
- OLMA N/A
- ITIC N/A
- P/E Ratio
- OLMA N/A
- ITIC $14.57
- Revenue Growth
- OLMA N/A
- ITIC 15.27
- 52 Week Low
- OLMA $2.86
- ITIC $190.20
- 52 Week High
- OLMA $13.93
- ITIC $290.40
- Technical
- Relative Strength Index (RSI)
- OLMA 66.97
- ITIC 56.36
- Support Level
- OLMA $7.49
- ITIC $245.11
- Resistance Level
- OLMA $8.25
- ITIC $257.39
- Average True Range (ATR)
- OLMA 0.66
- ITIC 4.69
- MACD
- OLMA 0.12
- ITIC -0.74
- Stochastic Oscillator
- OLMA 80.06
- ITIC 47.26
About OLMA Olema Pharmaceuticals Inc.
Olema Pharmaceuticals inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of next generation targeted therapies for women's cancers. Its therapies offer the potential to improve outcomes for women living with cancer. The company has completed discovery and preclinical studies of OP-1250. OP-3136 is another drug candidate in the company's product pipeline.
About ITIC Investors Title Company
Investors Title Co operates in the title insurance and exchange services sectors. The title insurance segment, conducted through ITIC and NITIC, offers title insurance policies for residential, commercial, and industrial properties in around 22 states and the District of Columbia, with a focus on the eastern United States. The title insurance segment issues title insurance policies through approved attorneys from underwriting offices and through independent issuing agents. Title insurance policies insure titles to real estate.n The Title Insurance segment contributes the majority of the company's revenue.